AQR Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Sell |
767,615
-253,021
| -25% | -$557K | ﹤0.01% | 1886 |
|
|
2025
Q1 | $1.18M | Sell |
1,020,636
-49,517
| -5% | -$57.4K | ﹤0.01% | 1926 |
|
|
2024
Q4 | $1.36M | Buy |
1,070,153
+693,956
| +184% | +$881K | ﹤0.01% | 1723 |
|
|
2024
Q3 | $1.28M | Buy |
376,197
+330,307
| +720% | +$1.13M | ﹤0.01% | 1733 |
|
|
2024
Q2 | $214K | Buy |
45,890
+24,758
| +117% | +$116K | ﹤0.01% | 2398 |
|
|
2024
Q1 | $157K | Buy |
+21,132
| New | +$157K | ﹤0.01% | 2292 |
|
|
2023
Q4 | – | Sell |
-36,933
| Closed | -$288K | – | 2355 |
|
|
2023
Q3 | $288K | Buy |
36,933
+9,158
| +33% | +$71.4K | ﹤0.01% | 2020 |
|
|
2023
Q2 | $229K | Sell |
27,775
-28,433
| -51% | -$234K | ﹤0.01% | 2043 |
|
|
2023
Q1 | $408K | Buy |
56,208
+23,446
| +72% | +$170K | ﹤0.01% | 1838 |
|
|
2022
Q4 | $291K | Buy |
+32,762
| New | +$291K | ﹤0.01% | 1980 |
|
|
2022
Q2 | – | Sell |
-48,899
| Closed | -$930K | – | 2205 |
|
|
2022
Q1 | $930K | Buy |
48,899
+34,773
| +246% | +$661K | ﹤0.01% | 1579 |
|
|
2021
Q4 | $375K | Sell |
14,126
-7,289
| -34% | -$194K | ﹤0.01% | 1916 |
|
|
2021
Q3 | $880K | Buy |
21,415
+5,176
| +32% | +$213K | ﹤0.01% | 1618 |
|
|
2021
Q2 | $920K | Sell |
16,239
-7,131
| -31% | -$404K | ﹤0.01% | 1625 |
|
|
2021
Q1 | $982K | Buy |
23,370
+6,988
| +43% | +$294K | ﹤0.01% | 1557 |
|
|
2020
Q4 | $1.15M | Sell |
16,382
-7,948
| -33% | -$557K | ﹤0.01% | 1442 |
|
|
2020
Q3 | $683K | Sell |
24,330
-11,362
| -32% | -$319K | ﹤0.01% | 1595 |
|
|
2020
Q2 | $1.06M | Sell |
35,692
-4,194
| -11% | -$124K | ﹤0.01% | 1435 |
|
|
2020
Q1 | $791K | Buy |
+39,886
| New | +$791K | ﹤0.01% | 1426 |
|
|
2018
Q4 | – | Sell |
-20,014
| Closed | -$637K | – | 2212 |
|
|
2018
Q3 | $637K | Buy |
20,014
+4,221
| +27% | +$134K | ﹤0.01% | 1872 |
|
|
2018
Q2 | $566K | Hold |
15,793
| – | – | ﹤0.01% | 1938 |
|
|
2018
Q1 | $524K | Buy |
15,793
+7,812
| +98% | +$259K | ﹤0.01% | 1895 |
|
|
2017
Q4 | $245K | Buy |
+7,981
| New | +$245K | ﹤0.01% | 2106 |
|